Ireland, Institutional

Changechevron_right

Private biotech investing in 2025

Nilesh Kumar, PhD, Head of Biotech Private Investments
4 min view
2026-02-28
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
nilesh-kumar

The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.

Nilesh Kumar, head of biotech private investing, shares his outlook for 2025, weighing headline risk against biotech venture capital's potential tailwinds.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • subtitles off, selected

      Expert

      Related insights

      Showing of Insights Posts
      Archived info
      Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

      CLO equity returns in a tight spread environment

      Continue reading
      event
      6 min
      Article
      2026-02-28
      Archived info
      Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

      Read next